共 6 条
[1]
Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol[J] . Manolis Markianos,John Hatzimanolis,Lefteris Lykouras.European Archives of Psychiatry and Clinical Neurosciences . 2001 (3)
[2]
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial[J] . P. Keck Jr,Alan Buffenstein,James Ferguson,John Feighner,William Jaffe,Edmund P. Harrigan,Marilyn R. Morrissey.Psychopharmacology . 1998 (2)
[3]
A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia[J] . D. P. van Kammen,J. P. McEvoy,S. D. Targum,D. Kardatzke,T. B. Sebree.Psychopharmacology . 1996 (1)
[4]
Mechanisms of action of atypical antipsychotic drugs: a critical analysis[J] . B. J. Kinon,J. A. Lieberman.Psychopharmacology . 1996 (1)
[5]
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT 2 receptors[J] . Josée E. Leysen,Paul M. F. Janssen,Alain Schotte,Walter H. M. L. Luyten,Anton A. H. P. Megens.Psychopharmacology . 1993 (1)
[6]
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects:role of 5HT2 receptors. Leysen JE, Janssen PMF, Schotte A, et al. Psychopharmacology . 1993